The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.


Download and Print: Download Printer-friendly PDF Download data


Table 23.15

Cancer of the Prostate (Invasive)

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2017
By Race/Ethnicity and Years Since Diagnosis

Race/Ethnicity Years Since Diagnosis Completee
0 to 5 >5 to 10 >10 to 15 >15 to 20 >20 to 25 <=25b >25d
All Races 900,214 953,463 678,436 418,862 184,721 3,135,696 34,643 3,170,339
White 701,239 769,223 563,050 354,061 159,744 2,547,317 36,576 2,583,893
Black 138,010 131,943 86,907 50,644 20,399 427,902 4,086 431,988
Asian/Pacific Islander 21,319 20,629 13,351 6,827 2,333 64,458 + +
Hispanic 59,273 57,004 38,768 20,529 7,678 183,252 + +

Estimated prevalence percent a on January 1, 2017, of the SEER population diagnosed in the previous 25 years
By Age at Prevalence and Race/Ethnicity

Race/Ethnicity Age Specific (Crude) Age-Adjustedc
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races 1.9646 0.0001 0.0002 0.0003 0.0007 0.0628 0.9938 4.9473 12.7506 17.7721 1.8324
White 2.0311 0.0002 0.0003 0.0003 0.0005 0.0480 0.8646 4.5811 12.2431 17.3251 1.7432
Black 1.9574 - - 0.0002 0.0017 0.1674 1.9500 8.2063 18.4635 22.7226 2.7051
Asian/Pacific Islander 0.6447 - - - - 0.0144 0.2968 1.9438 5.7590 9.4841 0.8397
Hispanic 0.6240 0.0002 0.0002 0.0001 0.0005 0.0286 0.5448 3.1347 9.2044 13.7068 1.3137

Footnotes:

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the Alaska Native Registry) and 1/1/2017 US population estimates based on the average of 2016 and 2017 population estimates from the US Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years.

b Maximum limited-duration prevalence is 25 years for 1992-2017 data.

c Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

d Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

e Complete prevalence is obtained by summing <=25 and >25.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.